Dow Jones futures rose slightly overnight, along with S&P 500 futures and Nasdaq futures.The stock market rally had a broad ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

Undoubtedly, one of the best growth stocks to own is Alphabet, the company that owns Waymo, Google, YouTube, Gemini, and ...

Researchers in Indianapolis are launching a first-of-its-kind study when it comes to GLP-1 drugs and the impact on the ...

The company’s latest preview report projects a guarded rebound for biopharma, as investor confidence returns and M&A activity ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

-- The Food and Drug Administration has extended its review of Eli Lilly's oral weight-loss drug orfoglipron, Reuters reported Thursday, citing internal FDA documents. -- A decision on the drug's ...

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.

SIDNEY — Sidney Middle School has announced its second quarter honor roll for the 2025-2026 school year as follows: ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Delaware sues drugmakers PBMs alleging a 15-year conspiracy to inflate insulin prices, impacting uninsured residents with diabetes.

In a separate development, Eli Lilly and Company (NYSE:LLY) announced on January 7 that it entered into a definitive ...